Logos Global Management as of Dec. 31, 2021
Portfolio Holdings for Logos Global Management
Logos Global Management holds 66 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alx Oncology Hldgs (ALXO) | 6.4 | $63M | 2.9M | 21.49 | |
Cytokinetics Com New (CYTK) | 6.2 | $60M | 1.3M | 45.58 | |
Design Therapeutics (DSGN) | 6.1 | $59M | 2.8M | 21.41 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 5.5 | $53M | 870k | 60.87 | |
Apellis Pharmaceuticals (APLS) | 4.9 | $47M | 1.0M | 47.28 | |
Dice Therapeutics | 4.3 | $42M | 1.7M | 25.31 | |
Karuna Therapeutics Ord | 4.1 | $39M | 300k | 131.00 | |
Dyne Therapeutics (DYN) | 4.0 | $39M | 3.2M | 11.89 | |
Aligos Therapeutics | 3.8 | $37M | 3.1M | 11.87 | |
Ideaya Biosciences (IDYA) | 3.8 | $37M | 1.6M | 23.64 | |
Ventyx Biosciences (VTYX) | 3.7 | $36M | 1.8M | 19.86 | |
Repare Therapeutics Ord (RPTX) | 3.7 | $36M | 1.7M | 21.09 | |
Olema Pharmaceuticals (OLMA) | 3.6 | $35M | 3.7M | 9.36 | |
Kezar Life Sciences | 2.5 | $24M | 1.5M | 16.72 | |
Forma Therapeutics Hldgs SHS | 2.3 | $23M | 1.6M | 14.22 | |
Global Blood Therapeutics In | 2.3 | $22M | 750k | 29.27 | |
Iveric Bio | 2.2 | $22M | 1.3M | 16.72 | |
Athira Pharma (ATHA) | 2.2 | $21M | 1.6M | 13.03 | |
Verve Therapeutics (VERV) | 1.7 | $16M | 443k | 36.87 | |
Alpine Immune Sciences | 1.6 | $16M | 1.1M | 13.85 | |
Harpoon Therapeutics | 1.5 | $15M | 1.9M | 7.55 | |
Edgewise Therapeutics (EWTX) | 1.3 | $13M | 850k | 15.28 | |
Kymera Therapeutics (KYMR) | 1.3 | $13M | 200k | 63.49 | |
Essa Pharma Com New (EPIX) | 1.3 | $12M | 865k | 14.20 | |
Fulcrum Therapeutics (FULC) | 1.2 | $12M | 685k | 17.69 | |
Jounce Therapeutics | 1.2 | $11M | 1.4M | 8.35 | |
Century Therapeutics (IPSC) | 1.0 | $9.7M | 614k | 15.86 | |
Relmada Therapeutics (RLMD) | 0.9 | $9.0M | 400k | 22.53 | |
Protagonist Therapeutics (PTGX) | 0.9 | $8.6M | 250k | 34.20 | |
Ngm Biopharmaceuticals | 0.9 | $8.4M | 475k | 17.71 | |
Mirati Therapeutics | 0.8 | $7.3M | 50k | 146.70 | |
Amicus Therapeutics (FOLD) | 0.7 | $7.2M | 625k | 11.55 | |
Tyra Biosciences (TYRA) | 0.7 | $6.7M | 473k | 14.07 | |
Compass Pathways Sponsored Ads (CMPS) | 0.7 | $6.6M | 300k | 22.10 | |
Landos Biopharma | 0.7 | $6.6M | 1.4M | 4.80 | |
Alnylam Pharmaceuticals (ALNY) | 0.6 | $5.9M | 35k | 169.57 | |
Eledon Pharmaceuticals (ELDN) | 0.6 | $5.9M | 1.3M | 4.41 | |
Zogenix Com New | 0.6 | $5.7M | 350k | 16.25 | |
Fate Therapeutics (FATE) | 0.6 | $5.5M | 94k | 58.51 | |
Arcutis Biotherapeutics (ARQT) | 0.5 | $5.2M | 250k | 20.74 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $5.1M | 455k | 11.26 | |
Graphite Bio | 0.5 | $5.1M | 406k | 12.43 | |
Talaris Therapeutics | 0.5 | $5.0M | 329k | 15.29 | |
Spruce Biosciences (SPRB) | 0.5 | $4.9M | 1.1M | 4.46 | |
Cullinan Oncology (CGEM) | 0.5 | $4.5M | 289k | 15.43 | |
Y Mabs Therapeutics (YMAB) | 0.4 | $4.1M | 250k | 16.21 | |
Vistagen Therapeutics Com New | 0.4 | $3.9M | 2.0M | 1.95 | |
Ikena Oncology (IKNA) | 0.4 | $3.8M | 300k | 12.54 | |
Janux Therapeutics (JANX) | 0.4 | $3.7M | 185k | 19.73 | |
Rain Therapeutics | 0.3 | $3.2M | 245k | 12.88 | |
Pyxis Oncology Common Stock (PYXS) | 0.3 | $3.1M | 287k | 10.97 | |
Travere Therapeutics (TVTX) | 0.3 | $3.1M | 100k | 31.04 | |
Nuvalent Inc-a (NUVL) | 0.3 | $2.6M | 135k | 19.03 | |
Lianbio Sponsored Ads (LIANY) | 0.3 | $2.5M | 413k | 6.16 | |
Wave Life Sciences SHS (WVE) | 0.3 | $2.5M | 800k | 3.14 | |
Somalogic Class A Com | 0.2 | $2.3M | 201k | 11.64 | |
Biomea Fusion (BMEA) | 0.2 | $1.9M | 252k | 7.45 | |
Marinus Pharmaceuticals Com New (MRNS) | 0.2 | $1.5M | 130k | 11.88 | |
Vera Therapeutics Cl A (VERA) | 0.1 | $1.3M | 50k | 26.72 | |
Cogent Biosciences (COGT) | 0.1 | $1.3M | 150k | 8.58 | |
Omega Therapeutics Common Stock (OMGA) | 0.1 | $999k | 88k | 11.32 | |
Verona Pharma Sponsored Ads (VRNA) | 0.1 | $820k | 122k | 6.72 | |
Day One Biopharmaceuticals I (DAWN) | 0.1 | $624k | 37k | 16.83 | |
Adagio Therapeutics (IVVD) | 0.1 | $508k | 70k | 7.26 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $126k | 67k | 1.89 | |
Mereo Biopharma Group Ads (MREO) | 0.0 | $75k | 47k | 1.60 |